04/25/2024
6:10 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Necina Roman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Kandera Reinhard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Winderlich Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Orlinger Klaus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:19 PM | Hookipa Pharma (Issuer)
Winderlich Mark (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
03/22/2024
6:33 AM | Hookipa Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
6:08 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
4:47 PM | Hookipa Pharma (Subject)
| Form SC 13G/A | |
02/14/2024
4:47 PM | EcoR1 Capital, LLC (Filed by)
EcoR1 Capital, LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G/A | |
01/31/2024
3:30 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
7:12 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
11:15 PM | Hookipa Pharma (Filer)
| Form EFFECT | |
12/22/2023
3:07 PM | GILEAD SCIENCES, INC. (Reporting)
Hookipa Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2023
6:33 AM | Hookipa Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/21/2023
6:06 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
3:46 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:05 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:10 AM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023
3:05 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
7:47 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
7:01 AM | Hookipa Pharma (Subject)
| Form SC TO-I/A | |
09/11/2023
7:23 AM | FMR LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G/A | |
08/10/2023
6:05 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:07 AM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/11/2023
5:21 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
4:06 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
6:37 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:06 PM | Hookipa Pharma (Issuer)
Kandera Reinhard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
10:04 AM | Hookipa Pharma (Subject)
Knoll Capital Management, LLC (Filed by)
| Form SC 13G | |
06/09/2023
4:13 PM | Coelho Mary Theresa (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:13 PM | Hookipa Pharma (Issuer)
Kaufman David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:14 PM | Hookipa Pharma (Issuer)
van de Winkel Jan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:15 PM | Hookipa Pharma (Issuer)
O'Neill Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:16 PM | Hookipa Pharma (Issuer)
Reilly Timothy P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:16 PM | Hookipa Pharma (Issuer)
Peters Malte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:17 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
4:24 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:03 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:14 AM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Elon Musk Secret Crypto Plot Exposed (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
